Xinhua Medical H1 Revenue Up 7.73% to RMB5.16 Billion, Net Profit Down 26.04%
Xinhua Medical reported first-half 2026 revenue of RMB5.16 billion, up 7.73% year on year, while net profit attributable to shareholders fell 26.04% to RMB285 million. During the period, the company launched several innovative products, including rehabilitation training devices, transcranial magnetic stimulation instruments, and automated microbial sample processing workstations.
In the first half of 2026, Xinhua Medical recorded operating revenue of RMB5.16 billion, an increase of 7.73% year on year. Net profit attributable to shareholders of the listed company stood at RMB285 million, down 26.04% from the same period last year.
During the reporting period, the company successfully launched multiple innovative products, including a four-limb linked rehabilitation training device, an upper- and lower-limb active-passive rehabilitation training system, a transcranial magnetic stimulation instrument, an animal anesthesia machine, a fully automated microbial sample processing workstation, and a rhythm comprehensive experimental chamber.